NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Vestiage™, Inc. (Pink Sheets:VEST), the emerging leader in healthy aging, announced today that it has completed R&D for two new products that it intends to launch in upcoming quarters. Utilizing the latest scientific advances and patented ingredients, substantiated with clinical studies and results, Vestiage, Inc. has a pipeline of new products to address the most in-demand issues for both men and women.
“We’re excited to be launching the latest addition to our RegiMEN™ line very soon,” said Scott Kimball, CEO of Vestiage, Inc. “We believe that RegiMEN TITANIUM™ Testosterone Support will be the only product of its kind on the market, containing four clinically tested, patented ingredients in an elegant formulation. This is the next generation of testosterone support for the industry. We don’t know of any natural product that will be able to match the results we expect this to deliver.” Retail price points for RegiMEN TITANIUM™ are expected to range between $129.99 and $149.99.
The second new product from Vestiage scheduled for launch is INTIMACY for Women™ by Monterey Bay Nutraceuticals™. “The formulation naturally addresses some of the largest concerns of many women in one simple product. There are many items currently on the market that address vitality and energy for men, but very few products exist for women. We’re changing that,” said Kimball.
INTIMACY for Women™ contains a patented natural ingredient with clinically tested results. The randomized, placebo-controlled, double-blind study involved 80 women with low sex drives who claimed to be in stable relationships. The results of the study, which focused on sexual vitality and desire, showed subjects reporting positive changes in both physiological and psychosocial aspects of sexual function – including arousal, orgasm, drive, sexual cognition, and a reduction in fatigue.
Both products are expected to be available online at the company’s websites and landing pages, as well as in select retail stores. Initially, RegiMEN TITANIUM™ is anticipated to be available exclusively with a yet unannounced major retailer for a limited period of time. INTIMACY for Women™ will be used as the leading product when Vestiage, Inc. launches its full Monterey Bay Nutraceuticals™ line through retail channels. Both new products will be available through the company’s monthly continuity program, which allows customers to purchase products conveniently on an automated basis.
Kimball added, “Our goal has always been to bring natural, safe, and innovative products to market while addressing the largest in-demand issues and concerns of astute, health-oriented, active men and women. We are achieving that goal and taking a major step forward with these two new products. With time, we feel we can reach our goal of one million men and one million women participating in our monthly continuity program, while nurturing significant presence within the major drug, grocery and specialty retailers in the USA.”
Vestiage™ (Pink Sheets:VEST) is a publicly traded emerging leader in healthy aging. The company specializes in bringing science-based products to the healthy-aging premium consumer through multiple channels utilizing a network of key partners that integrate production, fulfillment, customer service, advertising, sales, media, marketing, distribution, and new product development. Vestiage™ is focused on the use of marine/ocean and cutting-edge, botanically based science and patented ingredients to produce highly potent, elegantly formulated products with clinically proven ingredients. Using high potency and novel ingredient combinations, Vestiage™ creates and distributes multifunctional nutraceuticals such as RegiMEN™ for men (www.BuyRegimen.com) and Monterey Bay Nutraceuticals™ for women. (www.MontereyBayNutra.com). Vestiage™ brands address the top “in-demand” healthy-aging concerns of men and women. Vestiage™ research is focused on longevity and human performance science that covers both the cognitive and physical realms. To learn more, visit the company website, www.vestiageinc.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to our financial condition, results of operations and business. These forward-looking statements can be identified by the use of terms such as "believe," "expects," "plan," "intend," "may," "will," "should," "can," or "anticipates," or the negative thereof, or variations thereon, or comparable terminology, or by discussions of strategy. These statements involve known and unknown risks, uncertainties and other factors that may cause industry trends or our actual results to be materially different from any future results expressed or implied by these statements. Important factors that may cause our results to differ from these forward-looking statements include, but are not limited to: (i) changes in or new government regulations or increased enforcement of the same, (ii) unavailability of desirable acquisitions or inability to complete them, (iii) increased costs, including from increased raw material or energy prices, (iv) changes in general worldwide economic or political conditions, (v) adverse publicity or negative consumer perception regarding nutritional supplements, anti-aging or stem cell facial care products or stem cell technology in general, (vi) issues with obtaining raw materials of adequate quality or quantity, (vii) litigation and claims, including product liability, intellectual property and other types, (viii) disruptions from or following acquisitions including the loss of customers, (ix) increased competition, (x) slow or negative growth in the anti-aging or cosmetics, beauty, or nutritional supplement industry or the healthy foods or anti-aging channel, (xi) the loss of key personnel or the inability to manage our operations efficiently, (xii) problems with information management systems, manufacturing efficiencies and operations, (xiii) insurance coverage issues, (xiv) the volatility of the stock market generally and of our stock specifically, (xv) increases in the cost of borrowings or unavailability of additional debt or equity capital, or both, or fluctuations in foreign currencies, and (xvi) interruption of business or negative impact on sales and earnings due to acts of God, acts of war, terrorism, bio-terrorism, civil unrest and other factors outside of our control.